UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 12, 2024
(Exact name of registrant as specified in its charter)
(State or other jurisdiction of incorporation) | (Commission File Number) | (IRS Employer Identification No.) | ||||||||||||
(Address of principal executive offices)
(Zip Code)
(800 ) 603-4996
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
The | ||||||||||||||
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. Regulation FD Disclosure.
On March 12, 2024, The Beauty Health Company (the "Company") issued a press release announcing that the Company's Board of Directors (the "Board") has unanimously approved Marla Beck to be the Company's President and Chief Executive Officer, a copy of which is attached to this Current Report on Form 8-K ("Current Report") as Exhibit 99.1 and is incorporated herein by reference.
Ms. Beck has been the Interim Chief Executive Officer of the Company since November 20, 2023. Ms. Beck will also continue to serve on the Company's Board of Directors.
The Company intends to file a separate, subsequent Current Report on Form 8-K within four business days after the Company and Ms. Beck enter into a definitive employment agreement with respect to Ms. Beck becoming the Company's President and Chief Executive Officer.
The information set forth in Item 7.01 of this Current Report and Exhibit 99.1 contains forward-looking statements. These forward-looking statements are not guarantees of future performance and involve risks, uncertainties, and assumptions that are difficult to predict. Forward-looking statements are based upon assumptions as to future events that may not prove to be accurate. Actual outcomes and results may differ materially from what is expressed in these forward-looking statements.
The information set forth under Item 7.01 of this Current Report, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in Item 7.01 of this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing, except as expressly set forth by specific reference in such a filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.
Item 8.01. Other Events.
The information provided in “Item 7.01 - Regulation FD Disclosure” of this Current Report is incorporated by reference into this Item 8.01.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. | Description | |||||||
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) | |||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: March 12, 2024 | The Beauty Health Company | |||||||
| By: | /s/ Michael Monahan | |||||||
| Name: | Michael Monahan | |||||||
| Title: | Chief Financial Officer | |||||||
BeautyHealth Announces Appointment Of Marla Beck As
Chief Executive Officer
LONG BEACH, Calif., March 12, 2024 – The Beauty Health Company (NASDAQ: SKIN), home to flagship brand Hydrafacial, today announced its Board of Directors has unanimously approved Marla Beck as the Company’s permanent President and Chief Executive Officer. Ms. Beck has been Interim CEO since November 20, 2023, in addition to serving on the Company’s Board of Directors, which she will continue to do going forward.
“Over the past few months, the Board has undertaken an extensive search to identify BeautyHealth’s next CEO,” said Chairman of the Board Brent Saunders. “The Board unanimously agrees that Marla has done an outstanding job during her tenure as Interim CEO and that she is the right person to lead BeautyHealth into the future. Marla is an assured leader, focused on performance. As a beauty industry veteran, she brings a deep understanding of the sector and a track record of building enduring and authentic brands that deliver significant value. Marla possesses a deep understanding of the challenges and opportunities ahead for BeautyHealth, and the Board is confident in her steadying leadership.”
Before joining the BeautyHealth Board of Directors in June of 2022 and being appointed Interim Chief Executive Officer in November 2023, Ms. Beck established herself as a serial entrepreneur and visionary brand-builder. Ms. Beck is the founder and former CEO of Bluemercury, the disruptive omnichannel beauty and spa retailer founded in 1999. She led Bluemercury from inception to a strategic sale to Macy’s in 2015 and continued to lead the company as an independent business unit of Macy’s until 2021. Under Ms. Beck’s leadership, Bluemercury’s presence spanned nearly 200 brick and mortar stores, a thriving e-Commerce platform, a highly penetrated loyalty program, and private label product brands M-61 Powerful Skincare and Lune+Aster Cosmetics.
Prior to founding Bluemercury, Ms. Beck was a consultant at McKinsey & Company. Ms. Beck holds a Bachelor of Arts degree from the University of California, Berkeley; an MBA from Harvard Business School; and an MPA from Harvard’s John F. Kennedy School of Government.
“It is an honor to step into the role of CEO of BeautyHealth,” said Ms. Beck. “The Company and our brands intrigue and inspire me, much like they do the entire beauty and aesthetics industry. As I have spent time in the day-to-day operations, I am more confident than ever in BeautyHealth’s growth potential and Hydrafacial’s particular competitive positioning with providers, partners and consumers. The Company’s intrinsic strengths are unmatched; and, along with a renewed focus on operational excellence and financial rigor, I am confident we will drive meaningful growth and value for employees, providers and shareholders.”
About The Beauty Health Company
The Beauty Health Company (NASDAQ: SKIN) is a global category-creating company delivering millions of skin health experiences every year that help consumers reinvent their relationship with their skin, bodies and self-confidence. Our brands are pioneers: Hydrafacial™ in hydradermabrasion, SkinStylus™ in microneedling, and Keravive™ in scalp health. Together, with our powerful global community of estheticians, partners and consumers, we are personalizing skin health for all ages, genders, skin tones, and skin types. We are committed to being ever more mindful in how we conduct our business to positively impact our communities and the planet. Find a local provider at https://hydrafacial.com/find-a-provider, and learn more at beautyhealth.com or LinkedIn.
Investors: IR@beautyhealth.com
Press: press@beautyhealth.com
Press: press@beautyhealth.com